PAA 0.00% 18.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-926

  1. 11,478 Posts.
    lightbulb Created with Sketch. 5805
    There is also the possibility that MT is talking to BP
    MT was "engaging with Big Pharma last week" ID2T ,, he mentioned that in the presentation releasing Phase I/II Positive Data ..

    The Best indication was MT
    "We are close to selling MPL , Closer than anyone thinks"

    BP strategy would be to wait for ODD approval ,,, it qualifies and elevates MPL into the "Revenue" category the added value works both ways ,,, higher assurances and reduced risk for BP and significantly increases the Venture value for PAA as a Company..
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.000(0.00%)
Mkt cap ! $73.24M
Open High Low Value Volume
22.5¢ 24.0¢ 18.5¢ $2.617M 12.78M

Buyers (Bids)

No. Vol. Price($)
6 231369 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 50000 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
19.0¢
  Change
0.000 ( 4.17 %)
Open High Low Volume
23.5¢ 24.0¢ 18.5¢ 9241539
Last updated 16.02pm 17/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.